Literature DB >> 20865672

Risk factors for atrial fibrillation: Not always severe heart disease, not always so 'lonely'.

Marcin Rosiak1, Michał Dziuba, Michał Chudzik, Iwona Cygankiewicz, Karol Bartczak, Jarosław Drozdz, Jerzy Krzysztof Wranicz.   

Abstract

The precise mechanisms that cause atrial fibrillation (AF) are not completely understood. Clinicians should ask themselves whether AF is truly 'lone' or is the effect of an underlying, 'masked' disorder. Atrial fibrillation shares strong epidemiological associations with other cardiovascular diseases such as heart failure, coronary artery disease, valvular heart disease, diabetes mellitus and hypertension. In this review, we discuss the 'new risk factors' and the mechanisms by which they lead to AF. Based on the most recent studies, we present the current knowledge about the relationship between AF occurrence and the following disorders: metabolic syndrome and its components, sleep apnea and inflammation. Moreover, some aspects of the influence of lifestyle (alcohol consumption and physical activity) on AF events are described.

Entities:  

Mesh:

Year:  2010        PMID: 20865672

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  13 in total

1.  Meta-analysis of p-wave dispersion values in healthy individuals: the influence of clinical characteristics.

Authors:  Udi Nussinovitch
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

2.  The impact of age on the epidemiology of atrial fibrillation hospitalizations.

Authors:  Sahar Naderi; Yun Wang; Amy L Miller; Fátima Rodriguez; Mina K Chung; Martha J Radford; Joanne M Foody
Journal:  Am J Med       Date:  2013-10-16       Impact factor: 4.965

Review 3.  Impact of Metabolic Syndrome on Ablation-Outcome in Patients with Atrial Fibrillation: A Systematic Review.

Authors:  Sanghamitra Mohanty; Luigi Di Biase; Prasant Mohanty; Pasquale Santangeli; Bai Rong; Trivedy Chintan; David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Jason Zagrodzky; Andrea Natale
Journal:  J Atr Fibrillation       Date:  2013-02-12

4.  Clinically unrecognized mitral regurgitation is prevalent in lone atrial fibrillation.

Authors:  Sanjiv Sharma; Joel Lardizabal; Mark Monterroso; Neil Bhambi; Rohan Sharma; Rasham Sandhu; Sarabjeet Singh
Journal:  World J Cardiol       Date:  2012-05-26

5.  Role of Cholinergic Innervation and RGS2 in Atrial Arrhythmia.

Authors:  Douglas L Jones; Jari M Tuomi; Peter Chidiac
Journal:  Front Physiol       Date:  2012-06-29       Impact factor: 4.566

Review 6.  How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?

Authors:  Rajiv Sankaranarayanan; Graeme Kirkwood; Rajaverma Visweswariah; David J Fox
Journal:  Curr Cardiol Rev       Date:  2015

7.  A pilot study of circulating PPAR-γ receptor protein in elderly patients with atrial fibrillation.

Authors:  Qing Lin; Lina Jia; Yanshu Sun
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

8.  Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation.

Authors:  Ethan J Anderson; Jimmy T Efird; Stephen W Davies; Wesley T O'Neal; Timothy M Darden; Kathleen A Thayne; Lalage A Katunga; Linda C Kindell; T Bruce Ferguson; Curtis A Anderson; W Randolph Chitwood; Theodore C Koutlas; J Mark Williams; Evelio Rodriguez; Alan P Kypson
Journal:  J Am Heart Assoc       Date:  2014-02-26       Impact factor: 5.501

9.  The Association between Job Strain and Atrial Fibrillation: Results from the Swedish WOLF Study.

Authors:  Eleonor I Fransson; Magdalena Stadin; Maria Nordin; Dan Malm; Anders Knutsson; Lars Alfredsson; Peter J M Westerholm
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

10.  Differences in atrial fibrillation‑associated proteins between the left and right atrial appendages from patients with rheumatic mitral valve disease: A comparative proteomic analysis.

Authors:  Hai Liu; Guangxian Chen; Hongsheng Zheng; Han Qin; Mengya Liang; Kangni Feng; Zhongkai Wu
Journal:  Mol Med Rep       Date:  2016-09-26       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.